Veracyte, Inc. (VCYT) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Current Price
$36.27
Price Target
$47.25
Target Range
$43.00 — $50.00
Analyst Rating
Buy
Forward P/E22.0x
Trailing P/E44.2x
Forward PEG—
Implied Growth+102.0%
Median Target$48.00
Analyst Spread14.8%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$43
+18.6%
Consensus
$47
+30.3%
Bull Case
$50
+37.9%
Valuation Model TargetsConfidence: 54/100
Bear$-126
Base$67
Bull$60
VCYT Price Target Analysis
Updated March 5, 2026As of March 5, 2026, Veracyte, Inc. (VCYT) has a Wall Street consensus price target of $47.25, based on estimates from 20 covering analysts. With the stock currently trading at $36.27, this represents a potential upside of +30.3%. The company has a market capitalization of $2.88B.
Analyst price targets range from a low of $43.00 to a high of $50.00, representing a 15% spread in expectations. The median target of $48.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 13 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, VCYT trades at a trailing P/E of 44.2x and forward P/E of 22.0x. Analysts expect EPS to grow +102.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $66.79, with bear and bull scenarios of $-125.98 and $59.83 respectively. Model confidence stands at 54/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+40.9%
Avg Forward P/E42.0x
Peers with Coverage5 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
| VCYTVeracyte, Inc. | $2.9B | $36.27 | $47.25 | +30.3% | Buy | 22.0x | 20 |
 CAICaris Life Sciences, Inc. | $33.2B | $19.86 | $31.33 | +57.8% | Buy | 62.1x | 6 |
 ADPTAdaptive Biotechnologies Corporation | $2.5B | $16.44 | $21.25 | +29.3% | Buy | — | 17 |
 NAUTNautilus Biotechnology, Inc. | $331M | $2.62 | $2.50 | -4.6% | Buy | — | 5 |
 CDIOCardio Diagnostics Holdings, Inc. | $141M | $5.26 | — | — | — | — | — |
 SEERSeer, Inc. | $103M | $1.85 | — | — | Hold | — | 4 |
 IMDXInsight Molecular Diagnostics Inc. | $95M | $5.47 | $10.50 | +92.0% | Buy | — | 11 |
 ASBPAspire Biopharma Holdings, Inc. | $63M | $1.32 | — | — | — | — | — |
 YDESYD Bio Limited Ordinary Shares | $35M | $8.45 | — | — | — | — | — |
 AIMDAinos, Inc. | $7M | $1.51 | — | — | — | — | — |
Upside Potential Comparison
IMDXCAIVCYTADPTNAUTSee VCYT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VCYT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare VCYT vs LLY
See how VCYT stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
What is the VCYT stock price target for 2026?
The consensus Wall Street price target for VCYT is $47.25, representing 30.3% upside from the current price of $36.27. With 20 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is VCYT a buy, sell, or hold?
VCYT has a consensus rating of "Buy" based on 20 Wall Street analysts. The rating breakdown is predominantly bullish, with 13 Buy/Strong Buy ratings. The consensus 12-month price target of $47.25 implies 30.3% upside from current levels.
Is VCYT stock overvalued or undervalued?
VCYT trades at a forward P/E of 22.0285x, representing a moderate valuation. With analysts targeting $47.25 (30.3% implied move), the stock appears reasonably valued with upside.
How high can VCYT stock go?
The most bullish Wall Street analyst has a price target of $50 for VCYT, while the most conservative target is $43. The consensus of $47.25 represents the median expectation. Our quantitative valuation model projects a bull case target of $60 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover VCYT stock?
VCYT is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the VCYT stock forecast?
The 12-month VCYT stock forecast based on 20 Wall Street analysts shows a consensus price target of $47.25, with estimates ranging from $43 (bear case) to $50 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $67, with bear/bull scenarios of $-126/$60.
What is VCYT's fair value based on fundamentals?
Our quantitative valuation model calculates VCYT's fair value at $67 (base case), with a bear case of $-126 and bull case of $60. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 54/100.
What is VCYT's forward P/E ratio?
VCYT trades at a forward P/E ratio of 22.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 44.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy VCYT stock?
Wall Street analysts are very optimistic on VCYT, with a "Buy" consensus rating and $47.25 price target (30.3% upside). 13 of 20 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do VCYT price targets vary so much?
VCYT analyst price targets range from $43 to $50, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $47.25 consensus represents the middle ground. Our model's $-126-$60 range provides an independent fundamental perspective.